Abzena
Abzena is a biopharmaceutical contract research, development and manufacturing company headquartered in San Diego, California. Its origins date to PolyTherics in 2001; the Abzena business was established in 2013 by combining PolyTherics and Antitope. The company provides discovery, cell line development, process development, analytical testing and GMP manufacturing for complex biologics and bioconjugates, including antibody-drug conjugates. It operates facilities in the United States and Cambridge, United Kingdom, and offers proprietary platforms including AbZelectPRO for cell line development. Welsh, Carson, Anderson & Stowe acquired the company in 2018.
Key facts
| Company Operating Status | Acquired |
|---|---|
| Description | Abzena is a biopharmaceutical contract research, development and manufacturing company headquartered in San Diego, California. Its origins date to PolyTherics in 2001; the Abzena business was established in 2013 by combining PolyTherics and Antitope. The company provides discovery, cell line development, process development, analytical testing and GMP manufacturing for complex biologics and bioconjugates, including antibody-drug conjugates. It operates facilities in the United States and Cambridge, United Kingdom, and offers proprietary platforms including AbZelectPRO for cell line development. Welsh, Carson, Anderson & Stowe acquired the company in 2018. |
| Full Address | 360 George Patterson Blvd. Suite 101E Bristol PA 19007 USA |
| Wellfound ID | abzena |
Contact details
Email and phone for Abzena are available to signed-in members of InsureTable.
Sign in to view